Skip to main content

Articles By Julian Segan, MBBS, BMedSc, FRACP


Steroids in RA: Friend or foe (or both)?

23 November 2022

While have come so far from the days of our patients living on massive doses of steroids, we still have many patients who use steroids for our diseases, with increasing data for toxicity, even in low dose. As someone much smarter than me described them, steroids are our best frenemy.

Read Article

RA-ILD: an update

13 November 2022

Interstitial lung disease (ILD) remains a leading cause of mortality in rheumatoid arthritis (RA). Estimates of involvement of ILD in RA remain relatively imprecise (estimated prevalence 5-20%), though this partly reflects the wide spectrum of ILD and differing ascertainment.

Read Article
syringe, pill, DMARD, Treatment, therapy

Emerging and exciting treatments in RA: ACR22 preview

10 November 2022

Rheumatoid arthritis treatment has come leaps and bounds in recent decades. Gone are the days of gold injections, chemical synovectomies, and physician-mandated bedrest (heaven forbid). Though the marketplace for RA treatments is becoming ever more crowded, there are still unmet needs.

Read Article